Pietro Lampertico

Research interests

Publications

• EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

  Journal of Hepatology · 2025 · https://doi.org/10.1016/j.jhep.2025.03.018

• Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.10.043

• An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.04.055

• An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.09.025

• High rates of 30-day mortality in patients with cirrhosis and COVID-19

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.06.001

• aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.07.025

• Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.11.003

• Update of the statements on biology and clinical impact of occult hepatitis B virus infection

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.034

• EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.03.021

• The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

  Hepatology · 2017 · https://doi.org/10.1002/hep.29320

• Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

  The Journal of Experimental Medicine · 2007 · https://doi.org/10.1084/jem.20061287

• Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

  Hepatology · 2004 · https://doi.org/10.1002/hep.1840400418

Current projects

No projects listed.